How Ghana Slashed Child Malaria Deaths by 86% 23/06/2026 Selorm Kutsoati For decades, malaria has been one of Africa’s most persistent health challenges. In Ghana, it was once the leading cause of death for children under five. Bed nets and antimalarial drugs reduced deaths substantially, but by the mid-2010s, the pace of improvement had declined. Climate change was altering the length and intensity of transmission seasons. […] Continue reading -> Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Can We Win the Malaria Arms Race? 08/06/2026 Stefan Anderson GENEVA – Malaria has adapted and evolved for at least 30 million years. The oldest identified samples of the parasite were found in mosquitoes preserved in amber, from a family of insects ancient enough to have shared the planet with the dinosaurs. How many millions of people it has killed across the roughly 300,000 years […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Leading Malaria Scientist Warns Tools Alone Will Not End the Disease 14/06/2026 Health Policy Watch “Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading -> Can We Win the Malaria Arms Race? 08/06/2026 Stefan Anderson GENEVA – Malaria has adapted and evolved for at least 30 million years. The oldest identified samples of the parasite were found in mosquitoes preserved in amber, from a family of insects ancient enough to have shared the planet with the dinosaurs. How many millions of people it has killed across the roughly 300,000 years […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Can We Win the Malaria Arms Race? 08/06/2026 Stefan Anderson GENEVA – Malaria has adapted and evolved for at least 30 million years. The oldest identified samples of the parasite were found in mosquitoes preserved in amber, from a family of insects ancient enough to have shared the planet with the dinosaurs. How many millions of people it has killed across the roughly 300,000 years […] Continue reading -> World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
World Health Organization Gives Stamp of Approval to First Malaria Treatment for Young Infants 06/05/2026 Elaine Ruth Fletcher The World Health Organization has ‘pre-qualified’ Coartem® Baby, the first-ever malaria treatment for young infants of 4.5 kilograms or less. The combination treatment, now being rolled out in Ghana, aims to fill a longstanding gap in treatments available for children under the age of 5, who constitute three quarters of the estimated 610,000 malaria deaths […] Continue reading -> Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Malaria Funding Crisis and Drug Resistance Compel African Investment 28/04/2026 Felix Sassmannshausen GENEVA – As global health leaders gathered in Geneva on Monday to commemorate this year’s World Malaria Day, an advocacy forum featuring high-level diplomats addressed the rising threat of antimalarial drug resistance. Celebrations of medical progress and clinical discussions quickly gave way to discussion about a rapidly escalating malaria funding crisis, with more funding cuts […] Continue reading -> Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Africa Needs to Take Urgent Action to Protect ‘Miracle’ Malaria Drugs 24/04/2026 Fiona Walker Resistance to a key drug used to treat malaria in Africa is spreading. Experts warn action is now urgent and any delay will cost lives and create economic misery. Artemisinin-based combination therapy (ACT) is the main first-line malaria treatment used in Africa and the best available option, according to the World Health Organization (WHO). ACT […] Continue reading -> Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge 11/03/2026 Felix Sassmannshausen Battered by a 58% cut from France, a delayed European Union (EU) pledge, and a US pullback, the Global Fund faces a significant shortfall, securing $12.64 billion against its $18 billion target during the 8th replenishment. According to the organization, reaching the full target would have prevented roughly 400 million new AIDS, tuberculosis, and malaria […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts
Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Posts navigation Older posts